<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7035AE5D-F006-4762-9959-D965363291F6"><gtr:id>7035AE5D-F006-4762-9959-D965363291F6</gtr:id><gtr:name>Merck</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>Neuroscience Physiology and Pharmacology</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7035AE5D-F006-4762-9959-D965363291F6"><gtr:id>7035AE5D-F006-4762-9959-D965363291F6</gtr:id><gtr:name>Merck</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/78132E4B-F641-45DF-A5A9-D1CF2558D7C4"><gtr:id>78132E4B-F641-45DF-A5A9-D1CF2558D7C4</gtr:id><gtr:firstName>Trevor Graeme</gtr:firstName><gtr:surname>Smart</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/4C521556-823A-457B-931F-424427AF13A0"><gtr:id>4C521556-823A-457B-931F-424427AF13A0</gtr:id><gtr:firstName>stephen</gtr:firstName><gtr:surname>Moss</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G9603438"><gtr:id>35573112-5D13-463A-BBA8-B5710430FEA9</gtr:id><gtr:title>Mechanisms underlying GABA-A receptor inhibitory synapse construction and function</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G9603438</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2008-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>1997-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>3139365</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Merck</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>Mechanism of action of THIP</gtr:description><gtr:id>C46CAB80-6F6C-43F0-948D-CA0DD62A0312</gtr:id><gtr:impact>We have deduced at the molecular level how THiP activates GABA receptors. This drug was developed as a hypnotic and reached phase II trials. We have a publication currently under revision</gtr:impact><gtr:outcomeId>B51A6F2D497-1</gtr:outcomeId><gtr:partnerContribution>Provision of resources to study the action of this hypnotic</gtr:partnerContribution><gtr:piContribution>We used multi-disciplinary approaches to exactly determine how THIP acts at the GABA-A receptor deriving new infomation about how GABA-A receptors are activated.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Max Planck symposium Ringberg Castle, Munich: Intercellular communication in the nervous system, from development to roles in health and disease. Keynote Lecture: Structure-function studies on inhibitory amino acid receptors.</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>EE6EB680-7616-43EB-82A4-96513D6CEC8C</gtr:id><gtr:impact>Plenary lecture

Recognition by peers</gtr:impact><gtr:outcomeId>24DF5D088E4</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Paris, CNRS: Molecular regulation of the GABAA receptor.</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>7B75622E-7F8B-4D74-99D9-43F966798D52</gtr:id><gtr:impact>Lecture to academics &amp;amp; students

Recognition by peers, collaborative research links established</gtr:impact><gtr:outcomeId>DBBF7CA1F85</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>9th Winter Brain Conference, Solden, Austria: Electrophysiological approaches to study membrane dynamics of GABAA receptors in the brain.</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>518BB53A-FBE5-41B3-A948-591131D6C4AA</gtr:id><gtr:impact>Plenary lecture

Recognition by peers</gtr:impact><gtr:outcomeId>8D7CED02A22</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Eisai, UCL. The Inhibitory Synapse.</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>C3605E10-4CCB-4BDA-8039-DB8DFF65D52F</gtr:id><gtr:impact>Seminar to acadmics &amp;amp; industrialists

Part of Eisai scientific advisory board</gtr:impact><gtr:outcomeId>7169EB40371</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MRC Clinical Sciences Centre, Imperial College London:</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>25B969E3-A565-48A5-9600-3C6A4D552885</gtr:id><gtr:impact>Lecture to academics &amp;amp; students

Highlighting pharmacological approaches to CNS study</gtr:impact><gtr:outcomeId>5997AF1F147</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Scottish Neuroscience meeting: Plenary Keynote Lecture:</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>5E4C6F3E-4A99-408A-981E-4DF63BDF0179</gtr:id><gtr:impact>Plenary keynote lecture

Recognition by peers</gtr:impact><gtr:outcomeId>F2A43C4F256</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>UCL Institute Structural and Molecular Biology retreat, Keynote lecture: Molecular regulation of the GABAA receptor.</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>2005BF20-A180-403A-8FEA-F39E43163F5B</gtr:id><gtr:impact>Plenary lecture

Recognition by peers</gtr:impact><gtr:outcomeId>29C889057ED</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MRC Showcase Symposium, Neuroscience and Mental Health Board.</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A0970A92-E16A-428D-86DA-BE9D6DAC24B5</gtr:id><gtr:impact>Lecture to academics, clinicians &amp;amp; students, policy makers

part of MRC showcase</gtr:impact><gtr:outcomeId>DE2F4E021D7</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Kyoto symposium on Mechanisms of GABAergic Synaptic Transmission, Japanese Neuroscience Society meeting. Autocrine mGluR1 activation in cerebellar Purkinje cells regulates GABA-mediated synaptic inhibition.</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>BBE7620E-A024-45AE-9D9E-57008A8B75F6</gtr:id><gtr:impact>Plenary lecture

Representing UK neuroscience</gtr:impact><gtr:outcomeId>B1BE0ADC0E5</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Distinguished Gowdey Lecture</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>3F0F8273-EA32-4D1A-8CF4-DE8B82E6E043</gtr:id><gtr:impact>Prize lecture on GABA-A receptors, basic science and clinical

Recognition by peers</gtr:impact><gtr:outcomeId>612FFD71129</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>3200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Programme Grant</gtr:description><gtr:end>2012-07-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>G9722520</gtr:fundingRef><gtr:id>59CA5DDC-5FA9-4074-8162-E27B7AB56301</gtr:id><gtr:outcomeId>168466754880</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-07-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Non-invasive mutant that does not affect receptor function but allows its real-time trafficking to be resolved</gtr:description><gtr:id>69FEBE69-4725-4281-98C0-5B3EFEA0EDD8</gtr:id><gtr:impact>Revealed the speed and lateral mobility of GABA receptors in neuronal membranes for the first time</gtr:impact><gtr:outcomeId>qB9SWeqJeAH</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>GABA receptor channel mutant</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>EEE0C569-8CA4-470A-9801-45B635909E22</gtr:id><gtr:title>Retrograde activation of presynaptic NMDA receptors enhances GABA release at cerebellar interneuron-Purkinje cell synapses.</gtr:title><gtr:parentPublicationTitle>Nature neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/23288a146ff577acc03a03ddcc9c89bd"><gtr:id>23288a146ff577acc03a03ddcc9c89bd</gtr:id><gtr:otherNames>Duguid IC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>1097-6256</gtr:issn><gtr:outcomeId>5951716E65D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6FA48F08-7117-4F0C-97D0-5C1545A78D6E</gtr:id><gtr:title>Proton modulation of recombinant GABA(A) receptors: influence of GABA concentration and the beta subunit TM2-TM3 domain.</gtr:title><gtr:parentPublicationTitle>The Journal of physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ed0fd074168237c1eedafa78e4dc1a0c"><gtr:id>ed0fd074168237c1eedafa78e4dc1a0c</gtr:id><gtr:otherNames>Wilkins ME</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0022-3751</gtr:issn><gtr:outcomeId>B2B94362500</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>90E831C8-3B40-416A-84A9-D56471265357</gtr:id><gtr:title>Zn2+ ions: modulators of excitatory and inhibitory synaptic activity.</gtr:title><gtr:parentPublicationTitle>The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e568ab1412fca1c4dc62cb3bcfae9c6c"><gtr:id>e568ab1412fca1c4dc62cb3bcfae9c6c</gtr:id><gtr:otherNames>Smart TG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>1073-8584</gtr:issn><gtr:outcomeId>364A7C2F376</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E8B8B469-3734-4F65-848D-6F78ADCC4A70</gtr:id><gtr:title>Huntingtin-associated protein 1 regulates inhibitory synaptic transmission by modulating gamma-aminobutyric acid type A receptor membrane trafficking.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8b917950003555246b9239fd4c156c05"><gtr:id>8b917950003555246b9239fd4c156c05</gtr:id><gtr:otherNames>Kittler JT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>58F3A51FF70</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E9B6BD03-80C2-4C4D-85EC-E24F02733B4E</gtr:id><gtr:title>Mutations in the gene encoding GlyT2 (SLC6A5) define a presynaptic component of human startle disease.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2995c86c9ee0e08fabfa1196e5bea202"><gtr:id>2995c86c9ee0e08fabfa1196e5bea202</gtr:id><gtr:otherNames>Rees MI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>FBAF7746600</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G9603438</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>